
    
      Design: Randomized control trial Setting: Neonatal intensive care unit in a tertiary care
      hospital Patients: Patients diagnosed with MAS with PPHN according to clinical criteria. 97
      patients with MAS were enrolled in the study over a period of 8 months, out of which 40
      patients with PPHN were randomized into two groups.

      Intervention: Group A received Sildenafil through a feeding tube (1 mg/kg/dose q6h) for 8
      doses. Group B received a placebo. Outcome measures: Improvement in oxygen saturation (SpO2),
      oxygenation index (OI), duration of hospitalization and mechanical ventilation and mortality.
    
  